OAM
SRTA

Oxford Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Oxford Asset Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-43,868
Closed -$120K – 545
2025
Q1 		$120K Buy
+43,868
New +$157K 0.05% 411
2024
Q2 		– Sell
-64,127
Closed -$183K – 298
2024
Q1 		$183K Buy
+64,127
New +$198K 0.19% 198

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Oxford Asset Management's SRTA Position: Q2 2025 in Review

Oxford Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q2 2025, closing a stake of 43,868 shares — an estimated $120K sold.

Oxford Asset Management first reported a position in SRTA in Q1 2024 and held it in 2 quarters. The position peaked at $183K in Q1 2024. 126 funds tracked by Wall St. Rank hold SRTA as of Q2 2025.

  • Oxford Asset Management reported no remaining Strata Critical Medical Inc position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 43,868 Strata Critical Medical Inc shares in Q2 2025, an estimated $120K.
  • Oxford Asset Management first reported a position in Strata Critical Medical Inc in Q1 2024 and held it in 2 quarters.
  • Oxford Asset Management's Strata Critical Medical Inc position peaked at $183K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.